Experimental model of nephropathy associated with diabetes mellitus in mice

Pâmela Henrique Silva1, Patrícia Henrique Silva1, Adalberto Vieira Corazza2

  • 1Universidade Federal de Mato Grosso do Sul - Programa de Pós-Graduação em Saúde e Desenvolvimento na Região CentroOeste - Campo Grande (MS), Brazil.

Abstract

Insights

This study successfully created a low-cost, sustainable animal model for studying associated diabetes mellitus (DM) and nephropathy. This model, induced by ischemia-reperfusion and streptozotocin, offers a reliable basis for future research on chronic diseases.

Area of Science:

  • Biomedical Research
  • Animal Models
  • Chronic Disease Research

Background:

  • Nontransmissible chronic diseases like diabetes mellitus (DM) and nephropathy are prevalent and often require treatments for associated injuries.
  • Developing experimental models for studying comorbidities is crucial for advancing healing and regeneration research.

Purpose of the Study:

  • To establish a sustainable and cost-effective experimental model for inducing both nephropathy and diabetes mellitus (DM) in the same animal.
  • To provide a foundation for future studies on the healing and regeneration processes in the context of associated comorbidities.

Main Methods:

  • Sixty-four female Swiss mice were divided into control, nephropathy, DM, and combined nephropathy-DM groups.
  • Nephropathy was induced via ischemia-reperfusion (I/R) of the left kidney.
  • Diabetes mellitus was induced using streptozotocin (STZ) injection, followed by a hyperlipidemic diet and glucose solution.

Main Results:

  • The induction protocols for nephropathy and DM were sustainable, low-cost, and resulted in no animal deaths.
  • Early renal alterations, including changes in urine density, pH, glucose, protein, and leukocytes, were observed within 14 days.
  • Diabetes mellitus was confirmed by hyperglycemia, and the combined group exhibited significant weight loss and observable morphological kidney changes post-I/R.

Conclusions:

  • A simple, reliable, and cost-effective method for inducing associated nephropathy and diabetes mellitus in a single animal model was successfully developed.
  • Rapid tests confirmed the induction of both conditions, with no animal losses, establishing a valuable platform for future research.